跳转至内容
Merck
所有图片(1)

文件

MAB8694

Sigma-Aldrich

Anti-Hepatitis C Virus Antibody, NS5A

Chemicon®, from mouse

别名:

HCV

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

300

抗體表格

purified immunoglobulin

抗體產品種類

primary antibodies

無性繁殖

monoclonal

物種活性

human

製造商／商標名

Chemicon®

技術

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

同型

IgG1

運輸包裝

wet ice

特異性

Specific to HCV NS5A

免疫原

Recombinant protein to NS5A

應用

ELISA

Immunofluorescence

RIA

Western Blot

Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.

外觀

Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide

儲存和穩定性

Store at 2 to 8°C for up to 12 months from date of receipt.

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 产品选型工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Lisbeth C Robinson, Jonathan S Marchant, Lisbeth C Robinson, Jonathan S Marchant
Biochemical and biophysical research communications null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
Shao-Ru Chen et al.
Molecules (Basel, Switzerland), 21(10) (2016-10-19)
Hepatitis C virus (HCV) infects 200 million people worldwide, and 75% of HCV cases progress into chronic infections, which consequently cause cirrhosis and hepatocellular carcinoma. HCV infection is treated with currently considered standard drugs, including direct anti-viral agents (DAAs), alone
Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1?.
Matsui, C; Shoji, I; Kaneda, S; Sianipar, IR; Deng, L; Hotta, H
Journal of virology null
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门